Picture of Multiqure SA logo

MQR — Multiqure SA News Story

0.000.00%
pl flag iconLast trade - 00:00
IndustrialsHighly SpeculativeSmall CapSucker Stock

Brief: Pure Biologics Completes Project On Antibodies Selection Platform PureSelect2

Oct 29 (Reuters) - Pure Biologics SA  PUR1.WA :
    * COMPLETES REALISATION OF LAST STAGE OF PROJECT INCLUDING
DEVELOPMENT WORKS
    * PROJECT ON DEMONSTRATION OF EFFECTIVENESS OF PLATFORM FOR
SELECTION OF ANTIBODIES VIA IN VITRO METHOD PURESELECT2
    * ASSESSES DEGREE OF IMPLEMENTATION OF ALL PROJECT
MILESTONES AT
100%, ENTIRE PROJECT COMPLETE

Source text for Eikon:  ID:nEM3DbnJHa 
Further company coverage:  PUR1.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Multiqure SA

See all news